LI
LGND icon

Leap Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Leap Investments’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$503K Buy
+7,214
New +$457K 0.33% 110
2020
Q1 		– Sell
-15,389
Closed -$1M – 473
2019
Q4 		$1M Buy
+15,389
New +$1.03M 0.47% 58

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Leap Investments's LGND Position: Q2 2020 in Review

Leap Investments opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2020: 7,214 shares worth $503K. The stake represents 0.33% of the portfolio and ranks #110 among its holdings. This is a return to the name: Leap Investments previously reported a position in LGND as recently as Q4 2019.

Leap Investments first reported a position in LGND in Q4 2019 and has held it in 2 quarters since. The position peaked at $1M in Q4 2019. 262 funds tracked by Wall St. Rank hold LGND as of Q2 2020.

  • Leap Investments held 7,214 shares of Ligand Pharmaceuticals worth $503K as of Q2 2020.
  • Ligand Pharmaceuticals was a new Leap Investments position in Q2 2020.
  • Ligand Pharmaceuticals made up 0.33% of Leap Investments's portfolio in Q2 2020, its #110 holding.
  • Leap Investments first reported a position in Ligand Pharmaceuticals in Q4 2019 and has held it in 2 quarters since.
  • Leap Investments's Ligand Pharmaceuticals position peaked at $1M in Q4 2019.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.